Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions

Were any Phase 3 clinical trials conducted for Memoblast and what were the endpoints and outcomes?

Available reporting shows Mesoblast has conducted multiple Phase 3 trials of its cell‑therapy candidates (including rexlemestrocel‑L/revascor/rexlemestrocel‑L variants) and at least one Phase 3 trial ...